News
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
CVS Caremark decided to stop offering one product in favor of another for weight loss, the latest example of ...
While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...
The $7.8 million investment will fund further drug testing and development to advance its drug candidates to clinical trials.
However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...
Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-β) prodrug, CG-0416.
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback